Keystone Investors’s Medpace MEDP Stock Holding History

Keystone Investors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,400	Closed	-$1.78M	–	79
2024 Q1	$1.78M	Buy	+4,400	New	+$1.55M	0.15%	48

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Keystone Investors's MEDP Position: Q2 2024 in Review

Keystone Investors sold out of Medpace (MEDP) in Q2 2024, closing a stake of 4,400 shares — an estimated $1.78M sold.

Keystone Investors first reported a position in MEDP in Q1 2024 and held it in 1 quarter. The position peaked at $1.78M in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

Keystone Investors reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
Keystone Investors sold 4,400 Medpace shares in Q2 2024, an estimated $1.78M.
Keystone Investors first reported a position in Medpace in Q1 2024 and held it in 1 quarter.
Keystone Investors's Medpace position peaked at $1.78M in Q1 2024.
623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Keystone Investors's 13F filing for Q2 2024, filed 13 Aug 2024.